Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PegBio Co., Ltd. Capital/Financing Update 2017

Dec 27, 2017

50676_rns_2017-12-27_97545d89-2695-41bd-ae1c-e35bc5063528.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [272 x 54] intentionally omitted <==

CMBC CAPITAL HOLDINGS LIMITED

(Incorporated in Bermuda with limited liability)

(Stock Code: 1141)

VOLUNTARY ANNOUNCEMENT FINANCIAL ASSISTANCE FROM CONTROLLING SHAREHOLDER

This announcement is made by CMBC Capital Holdings Limited (the “ Company ”, together with its subsidiaries, the “ Group ”) on a voluntary basis. Reference is made to the announcement of the Company dated 23 July 2017 (the “ Announcement ”) concerning the provision of financial assistance by its controlling shareholder. Unless otherwise defined, capitalised terms used in this announcement shall have the same meanings as defined in the Announcement.

The Board is pleased to announce that on 20 December 2017, the Company entered into a supplemental facility letter (the “ Supplemental Facility Letter ”) with CMBCI, pursuant to which CMBCI agreed to increase the maximum principal amount of the Facilities by HK$2,000,000,000 (the “ Increased Facilities ”). As a result, the maximum aggregated outstanding principal amount of the Facilities at all time during the Availability Period increased to HK$5,000,000,000. The other terms and conditions of the Facility Agreement remain unchanged.

The Group intends to utilise the Increased Facilities for the purposes of, inter alia, developing its securities investment and provision of finance businesses.

– 1 –

CMBCI is a company incorporated in Hong Kong with limited liability. It is a controlling shareholder (as defined in the Listing Rules) of the Company and a connected person (as defined in the Listing Rules) of the Company. As such, the transactions contemplated under the Supplemental Facility Letter constitute connected transactions of the Company under Chapter 14A of the Listing Rules. Since the Supplemental Facility Letter has been entered into after arm’s length negotiation between the Company and CMBCI and determined on normal commercial terms or better and the Increased Facilities are not secured by any asset or guarantee of the Group, the Supplemental Facility Letter and the transactions contemplated thereunder are fully exempted from shareholders’ approval, annual review and all disclosure requirements under Rule 14A.90 of the Listing Rules.

By order of the Board CMBC Capital Holdings Limited Li Jinze Chairman

Hong Kong, 27 December 2017

As at the date of this announcement, the executive Directors are Mr. Li Jinze, Mr. Ding Zhisuo and Mr. Ng Hoi Kam, the non-executive Directors are Mr. Ren Hailong and Mr. Liao Zhaohui, and the independent non-executive Directors are Mr. Lee, Cheuk Yin Dannis, Mr. Wu Bin and Mr. Wang Lihua.

– 2 –